Measles Rubella Infections and Infestations Measles Rubella
Conditions
Interventions
Employing mix method approach, the use of RapidPro in all health facilities in 28 provinces and 395 districts during Phase 2 of the National Measles-Rubella campaign in Indonesia will be evaluated qua
Sponsors
Gavi, The Vaccine Alliance
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Participants should be any of the following: 1. Central level: Immunisation program managers at MoH, UNICEF, and WHO 2. Province level: Immunisation program managers at Province Health Offices 3. District level: Immunisation program managers at District Health Offices 4. Sub-district level: Immunisation coordinators at community health center (Pusat Kesehatan Masyarakat)
Exclusion criteria
Exclusion criteria: 1. Stakeholders who are not entering and/or receiving RapidPro data 2. Stakeholders who are not stationed at selected study sites 3. Stakeholders who decline to participate on study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| RapidPro effectiveness, translated as tracking immunisation coverage, assessed using secondary analysis of RapidPro data by comparing timely target achievement between highly vs moderate vs passive users on every two weeks during the campaign (August - October 2018) | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. RapidPro effectiveness, translated as perceived satisfaction, problem identification, and corrective action taken by RapidPro users, assessed using a mobile based survey in the final weeks of the campaign (end of September - October 2018) 2. Effective use of RapidPro, translated as stakeholders experience on using RapidPro to achieve and measure the achievement of the MR Campaign targets, assessed using an in-depth interview during the final weeks of the campaign (end of September - October 2018) | — |
Countries
Indonesia, South Africa
Contacts
Public ContactHafizah Jusril
Outcome results
None listed